266
Participants
Start Date
February 28, 2013
Primary Completion Date
December 31, 2015
Study Completion Date
December 31, 2015
DSC127
DSC127 0.03%, daily topical application to diabetic foot ulcer for a period of up to 28 days or until ulcer closure, whichever is sooner
placebo vehicle gel
Professional Education and Research Institute, Roanoke
East Carolina Foot and Ankle Specialists, Greenville
Carolina Musculoskeletel Institute, Aiken
UF Health Orthopaedic Surgery Clinic, Jacksonville
Barry University Clinical Research, North Miami Beach
GF Professional Research, Miami Lakes
Advanced Research Institute of Miami, Homestead
Miami Dade Medical Research Institute, Miami
Professional Health Care of Pinellas, St. Petersburg
WILMAX Clinical Research Inc, Mobile
ClinSearch, LLC, Chattanooga
LaPorte Medical Group, La Porte
Memorial Medical Group, Granger
Dallas VA Medical Center, Dallas
Fort Worth Diagnostic Clinic, Fort Worth
Endeavor Clinical Trials, San Antonio
Foot and Ankle Clinic, Los Angeles
UCLA Medical Center - Olive View, Sylmar
Orange County Research Center, Tustin
Brian O'Carroll, DPM, Inc., Pismo Beach
Roy O Kroeker, DPM, Inc, Fresno
Center for Clinical Research, Fair Oaks
Center for Clinical Research, Portland
Clinical Research Center, Eugene
Boston University Medical Center, Boston
Lead Sponsor
Collaborators (1)
Integrium
INDUSTRY
Integra LifeSciences Corporation
INDUSTRY